Hot flashes, brain fog, joint pain, skin thinning, mood instability, bladder urgency, bone loss. These do not seem connected. They appear to be a random collection of problems arriving at once.

They are not random. They share a common cause: the withdrawal of estrogen from tissues that have depended on it throughout adult life. Understanding where estrogen acts explains why its withdrawal has such wide-ranging effects.

Two Receptors, Almost Every Organ

Estrogen acts through two main receptor types: estrogen receptor alpha (ERα) and estrogen receptor beta (ERβ). These are proteins found inside cells that bind estrogen and activate gene expression. They are distributed across almost every organ system in the body, with different tissues expressing different receptor subtypes in different concentrations.[1]

ERα is expressed most heavily in: reproductive tissues (uterus, fallopian tubes, ovaries), breast tissue, bone, the liver, adipose (fat) tissue, and the cardiovascular system.

ERβ is expressed most heavily in: the brain and central nervous system, the cardiovascular system, the lung, the immune system, the colon, and the kidneys.

The overlap is extensive. Many tissues express both receptor types. Estrogen is a systemic hormone with regulatory functions throughout the body, not a reproductive-specific molecule with incidental effects elsewhere.

What Estrogen Does System by System

The nervous system. The brain has high concentrations of estrogen receptors, particularly ERβ, in the hippocampus (memory formation), prefrontal cortex (executive function, attention), and hypothalamus (temperature regulation, appetite, sleep). Estrogen supports dopamine synthesis, serotonin receptor sensitivity, acetylcholine activity, and synaptic plasticity across these regions.[2] Cognitive changes, mood instability, and sleep disruption are neurologically consistent consequences of estrogen decline.

The cardiovascular system. Estrogen supports endothelial function (the inner lining of blood vessels), reduces arterial stiffness, maintains healthy cholesterol ratios, and has anti-inflammatory and antioxidative effects in vascular tissue.[3] The lower cardiovascular disease incidence in premenopausal women compared to age-matched men, and the rise in cardiovascular risk after menopause, reflects the removal of this protection. Menopause is a cardiovascular risk event as much as a reproductive one.

Bone. Estrogen inhibits osteoclast activity (the cells that break down bone) and stimulates osteoblast activity (the cells that build it). As estrogen declines, the balance shifts toward net bone resorption. The 10% average bone density loss during the menopausal transition follows directly from this imbalance.[4] Bone expresses both ERα and ERβ, with ERα playing the dominant role in regulating bone remodeling.

Skin and connective tissue. Dermal fibroblasts express estrogen receptors and produce collagen in response to estrogen stimulation. The loss of approximately 30% of collagen types I and III within five years of menopause is an estrogen-dependent process. The same principle applies to connective tissue throughout the body, contributing to joint laxity and the musculoskeletal symptoms many women experience.

The genitourinary system. The vagina, urethra, and bladder base express high concentrations of estrogen receptors. Estrogen maintains the moisture, elasticity, and pH of these tissues. Genitourinary syndrome of menopause (GSM) is the collective term for the symptoms that result from estrogen withdrawal: vaginal dryness, pain, and urinary urgency.

The immune system. ERβ is prominently expressed in immune cells. Estrogen modulates immune responses, generally with anti-inflammatory effects. The increased systemic inflammation after menopause, reflected in raised CRP and pro-inflammatory cytokine levels, is partly attributable to the loss of estrogen's immunomodulatory function. This inflammatory shift contributes to cardiovascular risk, cognitive changes, joint pain, and metabolic dysfunction simultaneously.

Adipose tissue and metabolism. ERα expression in fat cells (adipocytes) influences where and how fat is stored. Estrogen promotes subcutaneous fat deposition (hips, thighs) and suppresses visceral fat accumulation (abdomen). When estrogen declines, this regulatory balance shifts, driving visceral fat redistribution.

Why Symptoms Emerge on Different Timescales

Acute symptoms (hot flashes, sleep disruption, mood changes) appear early because they reflect immediate neurological and thermoregulatory changes in systems that are highly sensitive to estrogen fluctuation.

Months to years later, genitourinary atrophy, skin thinning, and changes in body composition become apparent as estrogen-dependent tissue maintenance progressively fails.

Years to decades later, the consequences for bone density, cardiovascular health, and possibly cognitive decline reflect the long-term cumulative effect of estrogen withdrawal on systems where estrogen provided ongoing protection.

This timeline matters clinically. A woman who manages perimenopause without treatment and feels she has moved past it may not yet have experienced the skeletal, cardiovascular, and cognitive consequences still developing in the background.

Why HRT Affects So Many Systems at Once

The systemic distribution of estrogen receptors explains why HRT affects such a wide range of symptoms and health outcomes. It is not a drug with multiple coincidental effects. It is the replacement of a molecule that was regulating gene expression across dozens of tissue types, all of which are now operating without that input.

This also explains why women on HRT often report improvements they did not anticipate: better skin quality, reduced joint pain, improved energy alongside the expected reductions in hot flashes and improved sleep. Estrogen is restoring function in multiple receptor-expressing tissues simultaneously.

References

[1] Morani, A., Warner, M., Gustafsson, J. A. (2008). Biological functions and clinical implications of oestrogen receptors alfa and beta in epithelial tissues. Journal of Internal Medicine, 264(2), 128-142. See also: Role of estrogen receptors in health and disease. https://pmc.ncbi.nlm.nih.gov/articles/PMC9433670/

[2] Brinton, R. D., Yao, J., Yin, F., et al. (2015). Perimenopause as a neurological transition state. Nature Reviews Endocrinology, 11(7), 393-405. See also: Estrogen and brain. https://pmc.ncbi.nlm.nih.gov/articles/PMC10352578/

[3] Iorga, A., Cunningham, C. M., Moazeni, S., Ruffenach, G., Umar, S., Eghbali, M. (2017). The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy. Biology of Sex Differences, 8(1), 33. https://pmc.ncbi.nlm.nih.gov/articles/PMC9005843/

[4] Eastell, R., et al. (2016). Postmenopausal osteoporosis. Nature Reviews Disease Primers, 2, 16069. See also: Tissue-specific effects of loss of estrogen. https://pmc.ncbi.nlm.nih.gov/articles/PMC3356020/